GENPF (Genix Pharmaceuticals) Cyclically Adjusted Book per Share: $0.01 (As of Jan. 2026)


What is Genix Pharmaceuticals Cyclically Adjusted Book per Share?

Genix Pharmaceuticals GENPF Cyclically Adjusted Book per Share is $0.01 as of Jan. 2026. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Genix Pharmaceuticals's adjusted book value per share for the three months ended in Jan. 2026 was $-0.017. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.01 for the trailing ten years ended in Jan. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -12.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Genix Pharmaceuticals was 44.20% per year. The lowest was -30.70% per year. And the median was 0.00% per year.

As of today (2026-07-03), Genix Pharmaceuticals's current stock price is $0.0151. Genix Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2026 was $0.01. Genix Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genix Pharmaceuticals was 26.00. The lowest was 0.80. And the median was 5.50.


Genix Pharmaceuticals  (OTCPK:GENPF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Genix Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0151/0.01
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genix Pharmaceuticals was 26.00. The lowest was 0.80. And the median was 5.50.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Genix Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Genix Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Cyclically Adjusted Book per Share Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.00 0.02 0.02 0.01

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.03 0.01 0.01 0.01

GENPF vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Genix Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genix Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jan. 2026 was:

Adj_Book= Book Value per Share /CPI of Jan. 2026 (Change)*Current CPI (Jan. 2026)
=-0.017/130.3700*130.3700
=-0.017

Current CPI (Jan. 2026) = 130.3700.

Genix Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201604 0.008 101.370 0.010
201607 0.008 101.844 0.010
201610 0.007 102.002 0.009
201701 0.007 102.318 0.009
201704 0.006 103.029 0.008
201707 0.005 103.029 0.006
201710 0.003 103.424 0.004
201801 0.003 104.056 0.004
201804 0.001 105.320 0.001
201807 0.002 106.110 0.002
201810 0.003 105.952 0.004
201901 0.002 105.557 0.002
201904 -0.001 107.453 -0.001
201907 -0.001 108.243 -0.001
201910 -0.001 107.927 -0.001
202001 -0.002 108.085 -0.002
202004 0.009 107.216 0.011
202007 0.017 108.401 0.020
202010 0.062 108.638 0.074
202101 0.062 109.192 0.074
202104 0.059 110.851 0.069
202107 0.056 112.431 0.065
202110 0.055 113.695 0.063
202201 0.051 114.801 0.058
202204 0.049 118.357 0.054
202207 0.045 120.964 0.048
202210 0.039 121.517 0.042
202301 0.037 121.596 0.040
202304 0.034 123.571 0.036
202307 0.033 124.914 0.034
202310 -0.014 125.310 -0.015
202401 -0.015 125.072 -0.016
202404 -0.016 126.890 -0.016
202407 -0.017 128.075 -0.017
202410 -0.015 127.838 -0.015
202501 -0.015 127.443 -0.015
202504 -0.016 129.102 -0.016
202507 -0.018 130.290 -0.018
202510 -0.017 130.600 -0.017
202601 -0.017 130.370 -0.017

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.01 mean?
Genix Pharmaceuticals (GENPF) has a Cyclically Adjusted Book per Share of $0.01 as of Jan. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Genix Pharmaceuticals' current Cyclically Adjusted Book per Share is $0.01.
How does Genix Pharmaceuticals' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Genix Pharmaceuticals' Cyclically Adjusted Book per Share of $0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Cyclically Adjusted Book per Share is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Cyclically Adjusted Book per Share of $0.01. The current Cyclically Adjusted Book per Share is $0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Cyclically Adjusted Book per Share is $0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.